Associate Professor Ravindran Kanesvaran is a Deputy Chair and Senior Consultant in the Division of Medical Oncology of the National Cancer Centre Singapore ( NCCS). He is also an Associate Professor at Duke-NUS Graduate Medical School and clinical senior lecturer at the Yong Loo Lin School of Medicine, National University of Singapore. He did his medical oncology training at NCCS and a post exit fellowship in GU cancers and geriatric oncology at the Duke Cancer Institute , North Carolina, USA.
He is actively involved in graduate medical education and was the Program Director of the Medical Oncology Senior Residency Program from 2018-2021. At Duke NUS medical school, he was director of the Fundamentals in Clinic Practice course from 2017-2021. He was also the founding medical director of the medical oncology satellite centre at Sengkang Hospital ( 2018-2021). He has been awarded numerous awards for his outstanding clinical work including the following; Singhealth Outstanding Clinician of the year 2021, Singhealth Excellent Service Award 2018 (Silver), 2019 ( Gold ), 2021 ( STAR).
His research interests include genito-urinary oncology and geriatric oncology. He has published in a number of well-known peer reviewed journals including Journal of Clinical Oncology and Lancet Oncology. He is the author over 150 peer reviewed papers and of several textbook chapters. He has also been awarded a number of awards including the American Society of Clinical Oncology (ASCO GU) Merit Award 2009, American Association for Cancer Research (AACR) scholar-in-training Award 2010 and European Society of Medical Oncology (ESMO) fellowship award 2012. He is currently the Immediate Past President of the Singapore Society of Oncology (SSO) and the Singapore Geriatric Oncology Society. He is on the Editorial board of a number of leading journals including ESMO Open , Journal of Geriatric Oncology, Therapeutic Advances in Medical Oncology (TAM) and Annals of the Academy of Medicine Singapore.
He had been appointed as European Society of Medical Oncology (ESMO) Faculty 2015-2016 in Geriatric Oncology and 2016-2020 in GU Oncology ( 2017- to date). He is currently part of the SIOG-ESMO Cancer in the Elderly workgroup. He is an ESMO Council Member and member of the ESMO Public Policy Steering Committee as Chair of the ESMO Asia Pacific Public Policy Committee since 2018.He has been actively involved in the ESMO Leaders Generation Programme ( LGP) as faculty in 2018 and later as Co-Chair of the ESMO Asia LGP since 2019 and is a member of the ESMO Leadership Generation Task Force since 2019. He was the host and steering committee member of the first ESMO Asia meeting in 2015. Recently he led the development of the ESMO Pan Asian Adapted Guidelines (PAGA) for both renal cell carcinoma ( 2021) and Prostate Cancer ( 2021).
He is currently President ( 2020-2022) and the National Representative for Singapore in the International Society of Geriatric Oncology (SIOG). Prior to this he was Treasurer ( 2016-2018) and Board member of SIOG. He was awarded the first National Representative of the Year 2014 by SIOG at the Annual Meeting in Lisbon that year.
He is also the Vice Chairman of the Singapore Cancer Society (SCS), which is one of the largest non-governmental cancer based charities in the region. Apart from his role on the council of SCS , he is also the chair of the Cancer Treatment Fund ( which provides funding for cancer drugs for patients), Medical and Professional Audit Committee, and the Cancer rehabilitation committee.
Last Update: May 2022